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Summary: In this study our previously described selected method, a biuret procedure with deproteinization,
for the determination of spinal fluid protein is thoroughly discussed against the background of the results
found with a number of Lowry modifications. The use of various Separation techniques, i.e. deproteinization,
Ultrafiltration and chromatography (HPLC), for protein analysis ledj;o the question äs to whether low
molecular weight proteins in cerebrospinal fluid play an important role or not with respect to the choice of
a selected method for the determination of total protein.
Erneute kritische Überprüfung der Eignung des Biuretverfahrens zur Bestimmung des Liquorproteins
Zusammenfassung: Unsere kürzlich für die Bestimmung von Liquorprotein beschriebene ausgewählte Me-
thode — ein Biuretverfahren mit Enteiweißung — wird auf der Grundlage von Ergebnissen, die mit mehreren
Löwry-Modifikationen erhalten worden waren, erschöpfend diskutiert. Die Anwendung verschiedener Trenn-
verfahren, d. h. Enteiweißung, Ultrafiltration und Hochleistungsflüssigchromatographie in der Proteinanalytik
führte zu der Frage, ob Proteine mit niedrigem Molekulargewicht im Liquor eine bedeutende Rolle für die
Festsetzung einer ausgewählten Methode zur Bestimmung von Gesamtprotein spielen.
Introduction
In a previous article on the determination of total
protein in cerebrospinal fluid we briefly reviewed a
number of techniques with a view to recommending
a useful and well standardized method (1). To achieve
uniformity with the treatment of serum and plasma,
and for the sake of ä figidly defined Operation, we
chose the biuret teehnique.
Since then our experience with this method has
grown, and we have üsed it in several studies. We
still feel that this method was correctly chosen.
Nevertheless our curiosity with respect to the ex-
istence of the various Lowry variants remained. A
number of them are well documented and, justified
by their sensitivity, very populär in biochemistry and
clinical chemistry (2, 3, 4). Moreover, in the above
mentioned studies we sometimes found a non explain-
able difference between our biuret method and our
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routine method for estimating protein in spinal fluid,
which is a Lowry mödification (5), although both
methods normally correlate very well. Therefore we
decided to compare in detail a number of Lowry-
like techniques with our biuret method. It seemed
appropriate in this comparative study to use various
Separation techniques, i.e. deproteinization, ultra-




The materials used in this study were, where possible, of p. a.
quality, and1 handled exactly according to the instructions de-
scribed in the various procedures (see Methods).
The CSF samples were stored up to two weeks at + 4°C before
use.
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Methods
A very short description of all methods is given below. Fof
more details the reader is referred to the original articles (see
References).
Lowry modification according t o Papadopoulos (5)
Abbreviation: Papadopoulos.
Spinal fluid is diluted with sodium carbonate solution and
mixed with copper sulphate solution and, aftef Standing, phenol
reagent is added.
Lowry modification according to Peterson(6)
Abbreviation: Peterson without deproteinization.
Spinal fluid is diluted with water and aftefwards this solution
is mixed with a reagent containing copper sulphate, potassium
tartrate, sodium carbonate and sodium dodecyl sulphate.
Finally, phenol reagent is added.
Lowry modification according to Peterson with deproteinization
(6,7)
Abbreviation: Peterson with deproteinization.
Jhis method closely resembles the foregoing method 2 except
that there is no dilution with water, and deproteinization is
performed with sodium deoxycholate and trichloroacetic acid
solution. t f
Lowry modification according to Rieder (8)
Abbreviation: Rieder.
Spinal fluid is added to two Solutions: one containing copper
sulphate and one without copper sulphate ("blank"). After
standing phenol reagent is added.
Biuret procedure (1)
Abbreviation: biuret.
Spinal fluid is deproteinized with trichloroacetic acid or
phosphotungstic acid. The pellet is dissplved and mixed with
biuret reagent.
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Fig. 1. Split sample comparison between the various Lowry modifications (y-axis) and the biuret method (x-axis).
Calibration: human albumin.
The straight line represents the "ideal" correlation y = x.
a. Papadopoulos method vs. biuret
χ = 485 mg/1, y = 591 mg/1, n = 38.
b. Peterson method without deproteinization vs. biuret
χ = 485 mg/1, y = 582 mg/1, n = 32.
c. Peterson method with deproteinization vs. biuret
χ = 478 mg/1, y = 465 mg/1, n = 44.
d. Rieder method vs. biuret
χ = 530 mg/1, y = 578 mg/1, n = 38.
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U l t r a f i l t r a t i o n
An Amicon mini-ultrafiltration cell, model 3, equipped with
nitrogen inlet and Diaflo membrane was applied. The
membrane was a YM10 type, nominal molecular weight cuU
ofTlevel 10000 daltons.
High performance l iquid chromatography (HPLC)
We used the LK.B System developed for protein and peptide
separations consisting of a 2150 HPLC Pump, a 2154 Injector,
a 2135 Ultro Pac« TSKG 3000 SW gel filtration column,
7.5 χ 600 mm, a 2211 Super Rac Fraction Collector and a 215
Variable Wavelength Monitor, detection 280 nm. Elution: 0.1
mol/1 phosphate buffer-0.05 mol/1 NaCl pH 6.7; flow rate: 0.75
ml/min and sample volume: 500 μΐ.
Results
We started the study by comparing the various Lowry
modifications described under Materials and
Methods with our biuret technique. In the first in-
stance we decided to use the same Standard for all
methods i.e. human albumin, although we were
aware of the difference in colour intensity of the
various protein fractions with the Lowry method.
In figure l all comparisons are given. Most of the
spinal fluid samples were submitted to all the methods
of analysis.
It is striking, judging qualitatively, that both Lowry
modifications without deproteinization (fig. l a and
b) are comparable, whereas the other two using de-
proteinization (fig. l c) or correction (fig. l d) are only
partially comparable. In trying to find an explanation
for these phenomena we decided to study the in-
fluence of the Standard first. This was only applicable
to the Lowry modifications because with respect to
the biuret technique the various protein fractions did
not show any differences (1).
In figure 2 the results of the various determinations
are given.
From figure 2 it seemed clear that the contribution
of the Standard composition to the differences be-
tween the methods with and without deproteinization
mentioned in figure l, could only be moderate if
present at all.
So we continued by using the technique of ultrafiltr -
tipn. By means of our fo tine method for determin-
ing protein in spinal fluid (see Method Papadopoulos)
a nurriber of'CSF samples were estimated prior to
Ultrafiltration. After the tiltrafiltration these samples
were diluted with saline to the same volume s before
and again estimated with respect to the protein con-
tent. The ultrafiltrate was estimated s well.

















1.00 0.80 0.60 ΟΛΟ Albumin 0
0 Q20 ΟΛΟ 0.60 γ-Globul in 1.00
Froction in the mixture
Fig. 2. Absorbance values of various albumin/globulin
mixtures.
Albumin = 504 mg/1 human albumin = sei point.
Globulin = 498 mg/1 human γ-globulin
χ = biuret method
D = Lowry modification, Papadopoulos method
O = Lowry modification, Peterson method without
deproteinization
Π = Lowry modification, Peterson method with
deproteinization
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Fig; 3. x-axis: protein content prior to ultrafiltration
y-axis: protein content after ultrafiltration
χ: residue brought to original volume with saline
O: residue + ultrafiltrate
n = 18
The results tabulated in figure 3 gave rise to the
question s to whether the ultrafiltrate protein con-
tent caused the differences mentioned in figure l.
Therefore we feit the need to combine all experiments
while making use of the possibilities of high per-
formance liquid chromatography (HPLC). With our
Instrument and our gel permeation column we were
able to make a rough Separation between proteins
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of molecular weights ranging from several hundred
thousands to about two thousand. An overall
chromatogram for spinal fluid is given in figure 4.
applied the biuret äs well äs the Lowry reaction to
these samples. In figure 5 the results are given. The
protein positive fractions are shaded.
• Eluate
Fig. 4. HPLC-chromatogram of spinal fluid sample.
Part A: proteins, Mr < 20000
Part B: proteins, A/r > 20000
2 and 3 = peaks 2 and 3 covering proteins with Mv




Fig. 5. Chromatogram of remaining spinal fluid after de-
proteinization with trichloroacetic acid.
Parts A and B: see figure 4.
Diluted serum, which we used many times in pre-
liminary experiments, showed a comparable chro-
matogram, with the exception of that part where low
molecular weight proteins are recorded (part A). That
part proved to be flat.
Then we analysed the supernatant fluids of the
various deproteinized spinal fluid samples (de-
proteinization with phosphotungstic acid äs well äs
trichloroacetic acid). In all experiments depro-
teinization proved to be nearly complete with two
minor exceptions in the higher molecular weight
ränge (see figure 5, part B arrows). we did not study
possible differences between phosphotungstic acid
and trichloroacetic acid. In figure 5 only the chro-
matogram with trichloroacetic acid is given because
in part A the phosphotungstic acid complex is su-
perimposed on the rest of the peaks.
The analysis of the ultrafiltrates of spinal fluid gave
almost identical pictures with one important excep-
tion, i. e. part B of the chromatogram was flat.
It is clear from figures 4 and 5 that we focussed our
attention on the substances that showed absorption
at 280 nm and were recorded in part A of the
chromatogram. In the first instance we wondered
whether these fractions were protein-containing ör
not. We concentrated them by lyophilization and
• Eluate ·
Fig. 6. HPLC-chromatogram of spinal fluid and histogram of
protein values of corresponding colurnn fractions
tween dotted lines).
Finally, we tried to obtain a quantitative irnpression
of the low molecular weight proteins äs compäred
with the higher inolecular wqight proteins (part A
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and part B). We applied the most sensitive method
i.e. Peterson's Lowry modification without depro-
teinization (see Methods) to all fractions. The HPLC
column was loaded three times with a spinal fluid
sample. After fractionation, lyophilization and dis-
solution in 0.3 ml saline all fractions were measured.
In figure 6 a protein histogram in combination with
the recorded chromatogram is given.
Discussion
Reviewing all experiments described under Results äs
well äs the experiments mentioned in our previous
article we had to consider the interesting Situation of
possibly disavowing our Suggestion for the use of
the biuret method äs the reference method for the
determination of total protein in cerebrospinal fluid.
It is clear from this study that the low molecular
weight proteins (see flg. 4, 5 and 6) play an important
role in this reconsideration process.
As mentioned earlier, striking advantages of the
biuret procedure were the ease of Operation, including
stability of the reagents, the equality of the colour
intensity of the various protein fractions and, last but
not least, the uniformity with the serum procedure.
In this study we paid more attention to several Lowry
modifications. Not all these modifications were de-
veloped especially for spinal fluid analysis but we saw
no reason for not applying them.
One important remark has to be made first before
studying the results. Because albumin is used äs a
Standard, the Lowry results are slightly incorrect
(roughly 10% too high); this can be seen from
figure 2, and by considering the ratio albumin/glo-
bulin in spinal fluid. Therefore a qualitative (semi
quantitative) Interpretation is more appropriate.
As can be seen in figure l interesting differences ap-
pear when comparing these Lowry techniques with
our biuret method, especially against the background
of our findings with high performance liquid chro-
matography.
There is a striking correlation between the Lowry
procedure with deproteinization and our biuret
method (flg. l c); this also seems to be true for the
accuracy of the methods. Both the methods without
protein precipitation give pictures nearly identical
with thpse from the biuret procedure (see fig. l a and
b). We feit inclined to ascribe the differences found
in all these comparisons to the incompleteness of
deproteinization. Indeed there is some confirmation
of this view in the chromatograms (fig. 5 and 6).
However, the Lowry modification accprding to Rieder
does not use protein precipitation. The only differ-
ence between this method and the other two is a
blank correction for Lowry positive substances, such
äs some amino acids and other organic acids. Rieder's
method is well correlated with the biuret technique
(fig. l d). Knowing that the low molecular weight pro-
teins are coloured with Lowry's reagent in the Rieder
method the experiments shown in figuresla and b
and figure l d do conflict to a certain extent, since
these proteins are not or only partly precipitated in
the biuret procedure. Therefore the question arises
of whether this fraction is sufficiently important to
influence our biuret procedure. We have not studied
the nature and the quantity of this fraction in detail.
Since the cut-off level of the membrane used in the
ultrafiltration experiments is about 10000 daltons,
the molecular weights of the substances in part A
(fig. 4 and 5) are probably lower than 10000.
According to our experience with a number of pro-
teins of varying molecular weights (9 proteins, mo-
lecular weightsjranging from 3000 to 160000) we have
estimated the molecular weights of the protein(s) of
peak 3 to be about 7400 and those of peak 2 to be
about 2000. We do not yet know how many proteins
are involved in the low molecular weight part of the
chromatogram (9,10). From the data given in figure 6
it can be calculated that the low molecular weight
proteins comprise 15—20% of the total protein con-
tent of spinal fluid in the pool studied. The question
arises whether this part has a clinical significance or
not. We cannot yet answer this question. It is known
that spinal fluid can contain varying amounts of low
molecular weight proteins, depending on different
pathological conditions (11, 12). In fact we have seen
differences in the various spinal fluid samples used
in this study. These samples were chosen at random.
In a future study we hope to investigate this pheno-
menon further.
Considering all the methodological data, it is clear
that two questions still remain, i e. the value of the
deproteinization procedure of our own biuret method
and the value of the various Lowry procedures. With
respect to the first question it became clear from this
study that the deproteinization is not quantitative,
despite our earlier optimism. We have reasons to
believe that the deficit is not the above mentioned
15 — 20%. However, the exact quantity is a new
matter of study, äs well äs the problem of how to
precipitate all proteins, especially all low molecular
weight proteins.
Concerning all comparisons with Lowry (fig. 1), there
is in our opinion, no reason to consider changing
our original methodology and choice of a reference
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method. There is some uncertainty äs to what is
really measured by the Lowry method, which must be
considered a disadvantage. This includes the possible
different contributions of the various protein
fractions in spinal fluid (fig. 2). Calibration with
human serum (diluted) will give somewhat lower re-
sults for the Lowry like methods than the results
shown in figure l while the biuret data are maybe low
because of the possible deficiency in the precipitation
step. It is very difficult at this stage of the study to
make a clear choice.
This attempt to clarify certain discrepancies has
therefore developed into a new study of the protein
content of spinal fluid. We hppe to report more fully
on this aspect in the near future.
Acknowledgeiiients > r
Thanks are due to Ir. R. W. Wulkan and Dr. /. Lindemans for
practical help and stimulating comments.
The lyophüisation of the samples was done with the cordial
help of colleagues of the Department of Pharmacy (head: Dr.
J. W. Meilink)
References
1. Blijenberg, B.C., Hische, E.A.H., Kamp, H.H., Lamers,
K.J.B. & Souverijn, J.H.M. (1982) J. Clin. Chem. Clin.
Biochem. 20, 575-580.
2. Layne, E. (1957) Meth. Enzymol. 3, 447-454.
3. Peterson, G,L. (1983) Meth. Enzymol. 91, 95-119.
4. Peterson, G. L. (1979) Anal. Biochem. WO, 201-220.
5. Papadopoulos, N.M., Hess, W.C., O'Doherty, D. &
McLane, J.E. (1959) Clin. Chem. 5, 569-574.
6. Peterson, G. L. (1977) Anal. Biochem. 83, 346-356.
7. Bensadoun, A. & Weinstein, D. (1976) Anal. Biochem. 70,
241-250.
8. Rieder, H.P. (1966) Klin. Wochenschr. 44, 1036-1040.
9. Walravens, P., Laterre, B.C., Estas, A. 8t Heremans^ i. f.
(1967) Clin. Chim. Acta 18, 335-343.
10. Artiss, J. D., Thibert, R. J. & Zak, B. (1981) Clin. Biochem.
14, 32-38.
11. Cooper, E.H., Turner, R., Johns, E.A., Lindblom, H. &
Britton, V.J. (1983) Clin. Chem. 29, 1635-1640.
12. Post, R. M., Gold, P., Rubinow, D. R., Ballenger, J.C,
Bunney, W.E. & Goodwin, F.K. (1982) Life Sciences. 31,
1-15.
Dr. B. G. Blijenberg
Academic Hospital Rotterdam-Dijkzigt,
Department of Clinical Chemistry,
Dr. Molewaterplein 40,
NL-3015 GD Rotterdam
J. Clin. Chem. Clin. Biochem. / Vol. 23, 1985 / No. 4
